New drug aims to rescue cancer patients from chemotherapy side effect
NCT ID NCT06456528
Summary
This study is testing if an investigational drug called QL0911 can safely and effectively raise platelet counts in cancer patients. Low platelets, a common and serious side effect of chemotherapy, can force treatment delays. The goal is to help patients complete their planned cancer therapy on schedule.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER TREATMENT-INDUCED THROMBOCYTOPENIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Harbin First Hospital
RECRUITINGHarbin, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Nanjing Tianyinshan Hospital
RECRUITINGNanjing, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.